HRSA-22-079: National Hemophilia Program Coordinating Center
Closed
This grant is closed. A newer notice from the same program is open now: Women's Initiative for Screening and Health (WISH) (HRSA-27-072). Status: Closes January 8, 2027 (62 days left). It is in our archive of Health Resources and Services Administration notices from 2021.
Health Resources and Services Administration offered grants to the applicants described in the notice. It expected to make one award worth $740,000 in total. Applications closed on January 24, 2022.
From the official notice on Grants.gov, last changed October 26, 2021. Checked November 7, 2026.
- Total funding$740,000
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | October 26, 2021 |
|---|---|
| Deadline | January 24, 2022 |
| Archived by Grants.gov | March 25, 2022 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligible applicants for both funding opportunities include any domestic public or private entity, including an Indian tribe or tribal organization (as those terms are defined at 25 U.S.C. § 450b).See 42 CFR § 51a.3(a). Domestic faith-based and community-based organizations are eligible to apply.
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
The goal of HRSA-22-079 is for one recipient to provide subject matter expertise, technical assistance and programmatic support to the RHNs through a national coordinating center. HRSA-22-079 will enhance coordination across the regions, increase the programs’ ability to respond to emerging needs in the field, and strengthen the capacity of the RHN and HTC comprehensive care teams through targeted TA and by tracking national, regional, and patient-level data to assess patient outcomes. The NHPCC also provides an ongoing forum for national education, communication, and collaboration that assists in increasing the evidence base on care for patients seen in HTCs.
Who has won Special Projects of Regional and National Significance grants before
From fiscal 2021 to 2025, Special Projects of Regional and National Significance (93.110) awarded $1.4 billion across 842 grant awards, an average of $1.6 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Zero to Three National Center for Infants, Toddlers & Families | District of Columbia | 2 | $54.3 million |
| University Hospitals Cleveland Medical Center | Ohio | 1 | $51.5 million |
| Children's National Medical Center | District of Columbia | 1 | $37.2 million |
| University of North Carolina at Chapel Hill | North Carolina | 8 | $29.1 million |
| American Academy of Pediatrics | Illinois | 8 | $26.4 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, HRSA-27-072, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-22-079 still open?
No. It closed on January 24, 2022. A newer notice is open: HRSA-27-072, closes January 8, 2027 (62 days left).
Who can apply for National Hemophilia Program Coordinating Center?
Health Resources and Services Administration accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for National Hemophilia Program Coordinating Center?
Closed January 24, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $740,000 in total for one award.
Who has won Special Projects of Regional and National Significance grants before?
The largest recipients over five fiscal years were Zero to Three National Center for Infants, Toddlers & Families, University Hospitals Cleveland Medical Center, Children's National Medical Center. The program made 842 awards worth $1.4 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)